Mindray Medical International Ltd (ADR)  

(Public, NYSE:MR)   Watch this stock  
Find more results for MR
26.36
+0.52 (2.01%)
Jul 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 25.83 - 26.53
52 week 23.93 - 33.83
Open 26.05
Vol / Avg. 164,157.00/574,361.00
Mkt cap 3.03B
P/E 16.43
Div/yield 0.40/1.52
EPS 1.60
Shares 88.18M
Beta 1.09
Inst. own 104%
Aug 11, 2015
Q2 2015 Mindray Medical International Ltd Earnings Call - 8:00AM EDT - Add to calendar
Aug 10, 2015
Q2 2015 Mindray Medical International Ltd Earnings Release - 4:00PM EDT - Add to calendar
May 12, 2015
Q1 2015 Mindray Medical International Ltd Earnings Call - Webcast
May 11, 2015
Q1 2015 Mindray Medical International Ltd Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 12.41% 15.04%
Operating margin 11.35% 14.55%
EBITD margin - 19.30%
Return on average assets 5.49% 8.00%
Return on average equity 8.12% 12.40%
Employees 8,200 -
CDP Score - -

Address

Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan
SHENZHEN, GNG 518057
China
+86-755-26582888 (Phone)
+86-755-26582680 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Officers and directors

Hang Xu Chairman of the Board
Age: 50
Bio & Compensation  - Reuters
Xiting Li President, Co-Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Minghe Cheng Co-Chief Executive Officer, Chief Strategic Officer
Age: 51
Bio & Compensation  - Reuters
Alex Lung Chief Financial Officer
Age: 41
Bio & Compensation  - Reuters
Jie Liu Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
Jianxin Wang Chief Administrative Officer
Bio & Compensation  - Reuters
May Li Chief Investment Officer
Bio & Compensation  - Reuters
Fannie Lin Fan Group General Counsel, Secretary of Board of Directors
Age: 40
Bio & Compensation  - Reuters
Ronald H. Ede Director
Age: 54
Bio & Compensation  - Reuters
Qiyao Wu Director
Age: 76
Bio & Compensation  - Reuters